Company Name [desc] |
Country |
onkovis GmbH |
Germany |
Onkogen Kft. |
Hungary |
Oniria Therapeutics S.L. |
Spain |
OneChain Immunotherapeutics, S.L. |
Spain |
One-carbon Therapeutics AB |
Sweden |
OncoZenge AB |
Sweden |
Oncostellae S.L. |
Spain |
Oncoscience GmbH |
Germany |
Oncorena AB |
Sweden |
Oncoral Pharma ApS |
Denmark |
Oncoradiomics S.A. |
Belgium |
Oncopeptides AB (publ) |
Sweden |
Onconova Europe GmbH |
Germany |
OncoNano Medicine Limited |
Ireland |
OncoLize B.V. |
Netherlands |
Oncoinvent AS |
Norway |
Oncoheroes Biosciences S.L. |
Spain |
Oncodesign Precision Medicine |
France |
Ona Therapeutics |
Spain |
OmniSpirant Limited |
Ireland |
Omnicin Therapeutics B.V. |
Netherlands |
Omet Pharma AB |
Sweden |
Omeros Ireland Limited |
Ireland |
OMEICOS Therapeutics GmbH |
Germany |
Oloker Therapeutics srl |
Italy |
Olikla s.r.o. |
Czech Republic |
Olavide Neuron STX Sociedad Limitada |
Spain |
Oikonomou Aristi-Errieti (trading as Vigi-Care) |
Greece |
OGD2 Pharma |
France |
Odimma Therapeutics |
France |
ODDIFACT |
France |
Oculis ehf. |
Iceland |
Ocugen Limited |
Ireland |
OC Vigilance SL |
Spain |
Oblita Therapeutics bvba |
Belgium |
OBA-Pharma ApS |
Denmark |
O.S.K. LEDPHARM LTD |
Cyprus |
Nykode Therapeutics ASA |
Norway |
NWPharmaTech GmbH |
Austria |
NVT UAB |
Lithuania |
|